Latest News

Halting immune response could save brain cells after stroke

A new study in animals shows that using a compound to block the body?s immune response greatly reduces disability after a stroke. The study also showed that particular immune cells -- CD4+ T-cells produce a mediator, called interleukin (IL) -21 that can cause further damage in stroke tissue. Moreover, normal mice, ordinarily killed or disabled by an ischemic stroke, were given a shot of a compound that blocks the action of IL-21. Brain scans and brain sections showed that the treated mice suffered little or no stroke damage.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • MS drug candidate shows new promise

  • Pathway that contributes to Alzheimer's disease revealed by research

  • Domestic violence likely more frequent for same-sex couples

  • Physical activity in older adults linked to brain white-matter integrity

  • Targeted radiation, drug therapy combo less toxic for recurrent head, neck cancers

  • 3-D shape processing in brain: New discovery on how objects, places are processed

  • Suicide Prevention Requires Access to Effective, Evidence-Based Treatment

  • Down Syndrome helps researchers understand Alzheimer's disease

  • Providing private mental health service to veterans: Hurdles, challenges, advice

  • Gun deaths twice as high among African-Americans as white citizens in US

  •